Molecular Imaging and Biology

, Volume 19, Issue 1, pp 130–137

Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer

  • Anna G. Sorace
  • Anum K. Syed
  • Stephanie L. Barnes
  • C. Chad Quarles
  • Violeta Sanchez
  • Hakmook Kang
  • Thomas E. Yankeelov
Research Article

DOI: 10.1007/s11307-016-0994-1

Cite this article as:
Sorace, A.G., Syed, A.K., Barnes, S.L. et al. Mol Imaging Biol (2017) 19: 130. doi:10.1007/s11307-016-0994-1

Abstract

Purpose

Evaluation of [18F]fluoromisonidazole ([18F]FMISO)-positron emission tomography (PET) imaging as a metric for evaluating early response to trastuzumab therapy with histological validation in a murine model of HER2+ breast cancer.

Procedures

Mice with BT474, HER2+ tumors, were imaged with [18F]FMISO-PET during trastuzumab therapy. Pimonidazole staining was used to confirm hypoxia from imaging.

Results

[18F]FMISO-PET indicated significant decreases in hypoxia beginning on day 3 (P < 0.01) prior to changes in tumor size. These results were confirmed with pimonidazole staining on day 7 (P < 0.01); additionally, there was a significant positive linear correlation between histology and PET imaging (r2 = 0.85).

Conclusions

[18F]FMISO-PET is a clinically relevant modality which provides the opportunity to (1) predict response to HER2+ therapy before changes in tumor size and (2) identify decreases in hypoxia which has the potential to guide subsequent therapy.

Key words

FMISO Oxygenation Vascular maturation Herceptin BT474 Pimonidazole Misonidazole 

Funding information

Funder NameGrant NumberFunding Note
National Cancer Institute
  • U01CA174706
  • R01CA138599
  • U01CA142565
  • 5T32CA093240
  • R01 CA158079
Cancer Prevention and Research Institute of Texas (US)

    Copyright information

    © World Molecular Imaging Society 2016

    Authors and Affiliations

    • Anna G. Sorace
      • 1
    • Anum K. Syed
      • 2
    • Stephanie L. Barnes
      • 2
      • 3
    • C. Chad Quarles
      • 4
    • Violeta Sanchez
      • 5
    • Hakmook Kang
      • 6
    • Thomas E. Yankeelov
      • 1
      • 2
      • 3
    1. 1.Department of Internal Medicine, Dell Medical SchoolThe University of Texas at AustinAustinUSA
    2. 2.Department of Biomedical EngineeringThe University of Texas at AustinAustinUSA
    3. 3.Institute for Computational and Engineering SciencesThe University of Texas at AustinAustinUSA
    4. 4.Division of Imaging Research, Barrow Neurological InstituteSt. Joseph’s Hospital and Medical CenterPhoenixUSA
    5. 5.Department of PathologyVanderbilt University Medical CenterNashvilleUSA
    6. 6.Department of BiostatisticsVanderbilt University Medical CenterNashvilleUSA

    Personalised recommendations